A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits.
about
Dengue Fever: Causes, Complications, and Vaccine StrategiesPreclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccinesDengue vaccines: recent developments, ongoing challenges and current candidates.Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in mice.Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.
P2860
A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A dengue DNA vaccine formulate ...... in New Zealand white rabbits.
@en
type
label
A dengue DNA vaccine formulate ...... in New Zealand white rabbits.
@en
prefLabel
A dengue DNA vaccine formulate ...... in New Zealand white rabbits.
@en
P2093
P2860
P356
P1476
A dengue DNA vaccine formulate ...... in New Zealand white rabbits.
@en
P2093
Janine Danko
John Doukas
Kanakatte Raviprakash
Kevin Porter
Tadeusz Kochel
Thomas Luke
Timothy Burgess
P2860
P304
P356
10.4161/HV.21806
P577
2012-10-02T00:00:00Z